MicroRNAs and oncolytic viruses.
Explore this paper's citation graph
Summary
Oncolytic viruses have been used to enhance the delivery, duration and therapeutic efficacy of microRNA-based therapeutics designed to either restore or inhibit the function of dysregulated microRNAs in cancer cells.
- Type
- review
- Published
- 2015-08-01
- Cited by
- 63
- References
- 78
- OpenAlex
- https://openalex.org/W2013434241
- Semantic Scholar
- https://api.semanticscholar.org/CorpusID:43256722
Keywords
Oncolytic virus, Biology, microRNA, Virotherapy, Computational biology
References
- MicroRNA-sensitive oncolytic measles viruses for cancer-specific vector tropism.
- MicroRNA-regulated transgene expression systems for gene therapy and virotherapy.
- In vivo delivery of cytoplasmic RNA virus-derived miRNAs.
- Exploiting microRNA regulation for genetic engineering.
- Inhibiting the oncogenic mir-221 by microRNA sponge: toward microRNA-based therapeutics for hepatocellular carcinoma
- Tissue-Specific Attenuation of Oncolytic Sindbis Virus Without Compromised Genetic Stability
- microRNA Control of Lifespan and Metabolism
- MicroRNAs in Common Human Diseases
- MicroRNA-mediated species-specific attenuation of influenza A virus
- Harnessing endogenous miRNAs to control virus tissue tropism as a strategy for developing attenuated virus vaccines
- RNA viruses and the host microRNA machinery
- Primate-Specific miR-576-3p Sets Host Defense Signaling Threshold
- Influenza A virus utilizes suboptimal splicing to coordinate the timing of infection
- MicroRNAs and the regulation of vector tropism.
- miR-122a-regulated expression of a suicide gene prevents hepatotoxicity without altering antitumor effects in suicide gene therapy.
- Oncolytic adenovirus co-expressing miRNA-34a and IL-24 induces superior antitumor activity in experimental tumor model
- Potent antitumoral efficacy of a novel replicative adenovirus CNHK300 targeting telomerase-positive cancer cells
- MicroRNA and cancer--a brief overview.
- miRNAs and apoptosis: RNAs to die for
- Use of miRNA Response Sequences to Block Off-target Replication and Increase the Safety of an Unattenuated, Glioblastoma-targeted Oncolytic HSV.
Cited by
- Combining HDAC inhibitors with oncolytic virotherapy for cancer therapy
- Critical roles of microRNAs in the pathogenesis of systemic sclerosis: New advances, challenges and potential directions.
- Oncolytic virotherapy using herpes simplex virus: how far have we come?
- MicroRNA-555 has potent antiviral properties against poliovirus.
- MicroRNA-Detargeted Mengovirus for Oncolytic Virotherapy
- State of cancer in Bangladesh: An introductory review on microbiological perspective
- MicroRNA-regulated viral vectors for gene therapy.
- Oncolytic Viruses in Cancer Treatment: A Review
- Preclinical Evaluation of AdVince, an Oncolytic Adenovirus Adapted for Treatment of Liver Metastases from Neuroendocrine Cancer
- Complex Dynamics of Virus Spread from Low Infection Multiplicities: Implications for the Spread of Oncolytic Viruses
- MicroRNA-based Regulation of Picornavirus Tropism.
- Translational reprogramming in tumour cells can generate oncoselectivity in viral therapies
- Designing and building oncolytic viruses
- Oncolytic Virotherapy: A Contest between Apples and Oranges.
- Employing RNA viruses to fight cancer: novel insights into oncolytic virotherapy
- miR-142-5p Disrupts Neuronal Morphogenesis Underlying Porcine Hemagglutinating Encephalomyelitis Virus Infection by Targeting Ulk1
- Vesicular Stomatitis Virus is a Malleable Oncolytic Vector for the Treatment of Various Malignancies
- Viral MicroRNAs, Host MicroRNAs Regulating Viruses, and Bacterial MicroRNA-Like RNAs.
- Fighting Cancer with Mathematics and Viruses
- Advances in the mechanisms of action of cancer-targeting oncolytic viruses.
Related papers
- Oncolytic Virotherapy: An Advanced Microbial Approach for the Management of Cancer.
- Oncolytic virotherapy as promising immunotherapy against cancer: mechanisms of resistance to oncolytic viruses.
- Enhancing Oncolytic Virotherapy: Observations from a Voronoi Cell-Based Model.
- Mesenchymal stem cells as carrier cells to enable effective intratumoral delivery of oncolytic virus for oncolytic virotherapy: a systematic review
- Antiglioma oncolytic virotherapy: unattainable goal or a success story in the making?
- A multiscale mathematical model for oncolytic virotherapy.
- Modeling oncolytic virotherapy: is complete tumor-tropism too much of a good thing?
- Oncolytic virotherapy: Challenges and solutions.
- Generation of Genetically RGD σ1-Modified Oncolytic Reovirus That Enhances JAM-A-Independent Infection of Tumor Cells